astemizole has been researched along with Delayed Hypersensitivity in 1 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bierman, CW | 1 |
| Maxwell, D | 1 |
| Rytina, E | 1 |
| Emanuel, MB | 1 |
| Lee, TH | 1 |
1 trial available for astemizole and Delayed Hypersensitivity
| Article | Year |
|---|---|
Effect of H1-receptor blockade on late cutaneous reactions to antigen: a double-blind, controlled study.
Topics: Antigens; Astemizole; Benzimidazoles; Biopsy; Double-Blind Method; Eosinophils; Histamine H1 Antagon | 1991 |